Depression can be a debilitating illness that affects individuals of all ages, but especially middle-aged and older Australians who are at increased risk of reduced psychosocial functioning.
The Royal Melbourne Hospital (RMH) and The University of Melbourne (UoM) are conducting a groundbreaking study that could change the face of mental health treatment.
The RECOVER-D study is offering an innovative psychological treatment for individuals experiencing depressive symptoms, in combination with antidepressant medication.
Unlike traditional talk therapy, this new treatment focuses on training the underlying systems of the mind that help us with psychosocial function.
The psychosocial training targets three domains, including cognition, emotion processing, and social cognition.
Participants in the study will undergo eight sessions of personalised training delivered remotely online by a trained researcher, using video calls.
With Australians experiencing long wait times to access mental health services, the RECOVER-D study presents a unique opportunity for participants to continue their recovery from the comfort of their own homes.
RMH study lead, Professor Nicola Lautenschlager said the personalised training will consider the strengths and weaknesses of individuals in these domains, making it more beneficial than standardised training.
“We are looking for middle-aged and older adults experiencing depressive symptoms who are interested in participating in the study.,” Prof Lautenschlager said.
By taking part in this revolutionary treatment program, participants have the chance to improve their psychosocial functioning and regain their quality of life.
For more information, contact the RECOVER-D study team at (03) 8344 1879.
We provide a media service from 6am to 10pm each day. Journalists are welcome to contact our media advisor on-call via the RMH Switchboard on (03) 9342 7000.
During business hours, journalists can email mh-communications@mh.org.au. We do not respond to emails outside business hours.